When it comes to jobs in healthcare, working in the field of clinical research can be exciting and rewarding. There are many different opportunities available in the healthcare job field. If you are looking for a job in healthcare, consider looking into working into a clinical research company and look into the variety of opportunities […]
Read More
Do you ever wonder how prescription medications make their way to your local pharmacy? Clinical trials and health research play a vital role in maintaining the world population’s health on a regular basis. Without the proper research and clinical trials, many patients would still be suffering from ailments that are easily cured with medications now. […]
Read More
A Phase I study is the first time a new drug or treatment procedure is tested in-humans. The purpose of this phase is to determine the metabolism and pharmacologic actions of the drug in-humans, the side effects associated with increasing doses, and, if possible, to gain early evidence on effectiveness. Phase I studies in-human participants […]
Read More
Access to large markets where clinical trials that can investigate real patient needs, and do so in a rapid fashion, is invaluable for clinical research organisations. One such example of George Clinical rapid and access to huge markets took place in China, where diabetes patients numbered up to 90 million in 2010, and the most […]
Read More
Either because of financial, legal or operational reasons, many companies including those in healthcare, are still stuck in the paper world when it comes to data and document management. Now that technology has become so much more advanced, switching to electronic health data format has a slew of advantages and benefits that can’t and shouldn’t […]
Read More
George Clinical welcomes the development of the INVICTUS program which was launched at the World Heart Federation’s World Congress of Cardiology and Cardiovascular Health recently. The study, supported by Bayer AG and endorsed by the World Heart Federation, will be conducted by George Clinical in China and reinforces the importance of scientific leadership when undertaking […]
Read More
Philip Gregory of George Clinical – China, highlight South Korea’s capabilities in a three part series originally published on http://innovations.bbkworldwide.com/part-ii-insights-on-the-clinical-trial-landscape-of-south-korea. He provides insight on its recent clinical research developments that are driving innovation across the Asia-Pacific region. South Korea In comparison to Japan, South Korea has had a longer history of conducting global clinical trials. In fact, more than […]
Read More
George Clinical (GC) conducted a brief survey on sponsors who are currently not a customer of GC. 30 companies were surveyed by GC’s Business Development Managers across six countries which included the United States, China, Australia, Korea, United Kingdom and Israel. The primary objective of the survey was to determine the services and countries that were important […]
Read More
The cost of employee turnover in a Clinical Research Organisation (CRO) is high, as it weakens the relationship with the project sponsor. Research shows that in 2012, the CRO industry in the United States experienced a 12.5% voluntary turnover, compared to an average national voluntary turnover rate of 1.5%. During the 2015 financial year, George Clinical […]
Read MoreGeorge Clinical in China recently celebrated its second anniversary as an independent entity in China. Although George Clinical has been conducting Phase 11 to Phase IV studies in China for over 8 years, previously it was incorporated into The George Institute in China – but now operates as a separate legal entity. The last two […]
Read More
